To become one of the first countries in the world to produce this accelerated drug to treat Corona virus patients, Egypt's health authorities have declared successful the

production of Molnoperavir, which the US Drug and Food Agency recently agreed to put on the market in America and Britain.

In a statement, the Egyptian Medicines Authority stated that 5 Egyptian national companies had obtained a "license" to manufacture and trade the drug through "emergency use," as a first stage followed by the participation of a number of other companies in production.

The Egyptian Authority confirmed that medicine halves corona mortality rates.

The Egyptian Drug Authority described the treatment as "the first oral treatment for high - risk adults," explaining that it is being used under full medical supervision, according to the criteria of the Scientific Committee against Corona.

According to the Egyptian Drug Authority, "Molnopyravir" reduces the mortality rates of Corona patients by half of those at high risk, indicating that Egypt is the first country in the Middle East region to issue an emergency registration permit and to produce it locally.

Dr. Tamer Essam, the head of the Egyptian Drug Authority, earlier announced Egypt's success in achieving 100 percent self-sufficiency of medicines used in new corona virus treatment protocols, and the export of these products by many pharmaceutical companies to many countries around the world.

Locations

  • Address: United Kingdom

        1, Neil J Ireland, solicitor of

         25 Warwick Road -Coventry CV1 2EZ


  •   Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Castle Journal Group